Dr. Peter Attia, a prominent figure in the field of longevity and preventive health, has stepped down from his role as Chief Science Officer at David Protein, a high-protein nutrition bar maker. Attia, who is also the co-founder of the healthcare testing startup Biograph, has faced scrutiny due to his association with Jeffrey Epstein, as revealed in over 1,700 documents. Despite the controversy, Biograph has not commented on Attia’s ongoing involvement with the company.
David Protein, a three-year-old New York-based company, gained attention with its protein bar boasting 28 grams of protein, zero sugar, and 150 calories. The startup raised $75 million in Series A funding last year, indicating significant growth since its launch in 2024.
In a public statement, Attia expressed regret over inappropriate email content with Epstein but denied any criminal involvement or visits to Epstein’s properties. The fallout from his association extends beyond David Protein, potentially affecting Biograph’s operations and collaborative efforts. The tech community awaits further updates on how the startup will navigate this situation.
Source: TechCrunch